NCT04761185 2026-02-25
Raltitrexed in HIPEC
Fudan University
Phase 1 Completed
Clinical Trials
13 trialsNCT02562599 2022-02-22
Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin
Hubei Cancer Hospital
Phase 2 Completed
NCT02992886 2021-09-09
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
ChineseAMS
Phase 2 Completed
NCT01481545 2021-02-03
BRANCH
National Cancer Institute, Naples
Phase 2 Completed
NCT03083613 2021-02-01
Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT00002902 2019-03-13
Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT02723253 2016-03-30
Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 2 Completed
NCT00002828 2013-06-21
Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00003109 2013-04-17
Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors
Fox Chase Cancer Center
Phase 1 Completed
NCT00003528 2013-01-16
Raltitrexed in Treating Children With Refractory Acute Leukemia
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004920 2012-07-18
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00001341 2008-03-04
A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00590278 2008-01-25
TOMUDEX
AstraZeneca
Phase 2 Completed